Insights

Collaborative funding Nonprofit translational research institute with substantial external funding and active grants, presenting opportunities to align with philanthropic and government grant programs, co-development funding, and joint grant applications.

Clinical translation focus Strong emphasis on moving discoveries into clinical development across multiple disease areas, signaling opportunities to offer contract research, translational services, biomarker development, and CRO partnerships to accelerate pipelines.

Technology footprint Diverse tech stack including data and analytics platforms (S3, Salesforce, Veeva, PLINK) and enterprise tools (Ultimate Software, ADP), suggesting needs for data integration, cloud security, CRM-enabled collaboration, and workforce management solutions.

Immuno and vaccine leadership Active projects in vaccine development and immune-oncology with potential for collaboration on preclinical models, clinical trial support, manufacturing scale-up planning, and shared platforms for rapid vaccine development.

Strategic partnerships Part of Scripps Research with a mission-driven model and notable recent collaborations and funding initiatives, offering avenues for strategic alliances, joint ventures, technology licensing, and co-development agreements.

Similar companies to Calibr-Skaggs Institute for Innovative Medicines

Calibr-Skaggs Institute for Innovative Medicines Tech Stack

Calibr-Skaggs Institute for Innovative Medicines uses 8 technology products and services including MATLAB, iCIMS, AutoCAD, and more. Explore Calibr-Skaggs Institute for Innovative Medicines's tech stack below.

  • Advanced Analytics And Data Science
  • Applicant Tracking Systems
  • Cad & Graphics
  • Communication And Collaboration
  • Design
  • E-commerce
  • Human Resource Management System
  • IT Infrastructure & Operations Management

Media & News

Calibr-Skaggs Institute for Innovative Medicines's Email Address Formats

Calibr-Skaggs Institute for Innovative Medicines uses at least 2 format(s):
Calibr-Skaggs Institute for Innovative Medicines Email FormatsExamplePercentage
FLast@calibr.orgJDoe@calibr.org
95%
F-Last@calibr.orgJ-Doe@calibr.org
2%
LastF@calibr.orgDoeJ@calibr.org
2%
LF@calibr.orgDJ@calibr.org
1%
FLast@scripps.eduJDoe@scripps.edu
84%
Last@scripps.eduDoe@scripps.edu
7%
FirstLast@scripps.eduJohnDoe@scripps.edu
5%
FirstL@scripps.eduJohnD@scripps.edu
4%

Frequently Asked Questions

What is Calibr-Skaggs Institute for Innovative Medicines's official website and social media links?

Minus sign iconPlus sign icon
Calibr-Skaggs Institute for Innovative Medicines's official website is scripps.edu and has social profiles on LinkedIn.

How much revenue does Calibr-Skaggs Institute for Innovative Medicines generate?

Minus sign iconPlus sign icon
As of August 2026, Calibr-Skaggs Institute for Innovative Medicines's annual revenue is estimated to be $50M - $100M.

What is Calibr-Skaggs Institute for Innovative Medicines's SIC code NAICS code?

Minus sign iconPlus sign icon
Calibr-Skaggs Institute for Innovative Medicines's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Calibr-Skaggs Institute for Innovative Medicines have currently?

Minus sign iconPlus sign icon
As of August 2026, Calibr-Skaggs Institute for Innovative Medicines has approximately 138 employees across 4 continents, including North AmericaAsiaEurope. Key team members include Associate Director Of Grants: R. H.Principal Investigator: A. D.Administrative Assistant Ii: C. V.. Explore Calibr-Skaggs Institute for Innovative Medicines's employee directory with LeadIQ.

What industry does Calibr-Skaggs Institute for Innovative Medicines belong to?

Minus sign iconPlus sign icon
Calibr-Skaggs Institute for Innovative Medicines operates in the Biotechnology Research industry.

What technology does Calibr-Skaggs Institute for Innovative Medicines use?

Minus sign iconPlus sign icon
Calibr-Skaggs Institute for Innovative Medicines's tech stack includes MATLABiCIMSAutoCADGitHubSketchNetSuiteADPNagios.

What is Calibr-Skaggs Institute for Innovative Medicines's email format?

Minus sign iconPlus sign icon
Calibr-Skaggs Institute for Innovative Medicines's email format typically follows the pattern of FLast@calibr.org. Find more Calibr-Skaggs Institute for Innovative Medicines email formats with LeadIQ.

When was Calibr-Skaggs Institute for Innovative Medicines founded?

Minus sign iconPlus sign icon
Calibr-Skaggs Institute for Innovative Medicines was founded in 2012.
Calibr-Skaggs Institute for Innovative Medicines logo

Calibr-Skaggs Institute for Innovative Medicines

Biotechnology ResearchCalifornia, United States51-200 Employees

The Calibr-Skaggs Institute for Innovative Medicines is a translational research organization in biotechnology focused on accelerating the development of new medicines to address critical unmet medical needs. It operates as a division of Scripps Research, a large private nonprofit biomedical research organization in the United States recognized for its impact on innovation. As a nonprofit drug discovery engine, the institute moves treatments from discovery toward clinical development across multiple disease areas. Based in La Jolla, California, at 11119 North Torrey Pines Road, it employs between 51 and 200 people. The organization maintains a self-sustaining model that supports bold exploration and aims to translate ideas into clinical development using a broad range of scientific approaches and technologies. Reported revenue falls in the range of $50 million to $100 million.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2012
Employees
51-200

Section iconFunding & Financials

  • $50M - $100M

    Calibr-Skaggs Institute for Innovative Medicines's revenue is estimated to be in the range of $50M - $100M

Section iconFunding & Financials

  • $50M - $100M

    Calibr-Skaggs Institute for Innovative Medicines's revenue is estimated to be in the range of $50M - $100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.